For the year ending 2025-12-31, COYA has $49,950,245 in assets. $6,922,015 in debts. $46,822,786 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 46,822,786 | |||
| Prepaids and other current assets | 3,116,232 | |||
| Total current assets | 49,939,018 | |||
| Fixed assets, net | 11,227 | |||
| Total assets | 49,950,245 | |||
| Accounts payable | 1,061,122 | |||
| Accrued expenses | 3,612,913 | |||
| Deferred collaboration revenue | 1,197,856 | |||
| Total current liabilities | 5,871,891 | |||
| Deferred collaboration revenue | 1,050,124 | |||
| Total liabilities | 6,922,015 | |||
| Common stock, 0.0001 par value 200,000,000 shares authorized 20,934,456 and 16,707,441 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 2,094 | |||
| Additional paid-in capital | 104,989,413 | |||
| Accumulated deficit | -61,963,277 | |||
| Total stockholders' equity | 43,028,230 | |||
| Total liabilities and stockholders' equity | 49,950,245 | |||
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA)